Mutations and polymorphisms associated with antiretroviral drugs in HIV-1C-infected African patients.
Doualla-Bell
Florence
F
Botswana-Harvard AIDS Institute Partnership for HIV Research and Education, Gaborone, Botswana.
Gaseitsiwe
Simane
S
Ndungú
Thumbi
T
Modukanele
Musetsanagepe
M
Peter
Trevor
T
Novitsky
Vladimir
V
Ndwapi
Ndwapi
N
Tendani
Gaolathe
G
Avalos
Ava
A
Wester
William
W
Bussmann
Hermann
H
Cardiello
Peter
P
Marlink
Richard
R
Moffat
Howard
H
Thior
Ibou
I
Wainberg
Mark A
MA
Essex
Max
M
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy* / Q000276:immunology / Q000821:virology*; D019380:Anti-HIV Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001902:Botswana; D018984:Epitopes, T-Lymphocyte / Q000737:chemistry / Q000235:genetics / Q000276:immunology; D005500:Follow-Up Studies; D016333:HIV Protease / Q000235:genetics / Q000378:metabolism; D015497:HIV-1 / Q000187:drug effects* / Q000201:enzymology / Q000235:genetics* / Q000502:physiology; D006801:Humans; D009154:Mutation / Q000235:genetics*; D010802:Phylogeny; D011110:Polymorphism, Genetic / Q000235:genetics*; D012194:RNA-Directed DNA Polymerase / Q000235:genetics / Q000378:metabolism; D013601:T-Lymphocytes / Q000276:immunology
D019380:Anti-HIV Agents; D018984:Epitopes, T-Lymphocyte; D012194:RNA-Directed DNA Polymerase; D016333:HIV Protease